BOSTON SCIENTIFIC CORPORATION Deferred Revenue
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Revenue of $359.00 million as of 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2025-11-03
- 2025-09-30: Deferred Revenue $359.00M.
- 2025-06-30: Deferred Revenue $349.00M.
- 2025-03-31: Deferred Revenue $335.00M.
- 2024-12-31: Deferred Revenue $329.00M.
| Period end | Deferred Revenue |
|---|---|
| 2025-09-30 | $359.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $349.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $335.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $329.00M 10-Q · filed 2025-11-03 |
| 2024-09-30 | $328.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $316.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $314.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $311.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $301.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $295.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $290.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $289.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $278.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $279.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $279.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $276.00M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $296.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $283.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $264.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $257.00M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $258.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $251.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $251.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $257.00M 10-Q · filed 2020-11-05 |
| 2018-06-30 | $384.00M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $393.00M 10-Q · filed 2018-05-01 |
| 2018-01-01 | $411.00M 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |